Presentation TCT 2015 Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? Oral or Crushed Ticagrelor for All! Presenter: C. Michael Gibson, Marco Valgimigli, Guido Parodi October 11, 2015
News Conference News TCT 2015 Experts Debate Optimal Pharmacologic Approach for STEMI Patients October 11, 2015
News Conference News TCT 2014 Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation Todd Neale October 10, 2014
News Conference News TCT 2014 PLATO Subanalysis: Ticagrelor Safe, Effective in Primary PCI September 15, 2014
Presentation TCT 2014 No: Vorapaxar Is Effective, but Prasugrel and Ticagrelor are Preferred! Presenter: Dirk Sibbing September 14, 2014
Presentation TCT 2014 The Case for Selective Use of Prasugrel and Ticagrelor in PCI Patients with Stable CAD Presenter: Robert A. Harrington, Ajay J. Kirtane, Thomas D. Stuckey, Matthew J. Price September 14, 2014
Presentation TCT 2013 Mortality Trumps All: Ticagrelor for (Nearly) All! Presenter: Michel Le May October 31, 2013
Presentation TCT 2013 Emerging Ticagrelor Data: Insights Into its Safety and Efficacy Profile Presenter: Dimitrios Alexopoulos October 31, 2013
News Conference News TCT 2013 Studies Find Differing Benefits of Platelet, Genotype Testing October 31, 2013
Presentation TCT 2013 Pre-load wtih Platelet ADP Receptor Inhibition in STEMI: Prasugrel, Ticagrelor, Clopidogrel, Or Does it Matter? Presenter: Michel Le May October 30, 2013
News Conference News TCT 2013 EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI October 30, 2013
Presentation TCT 2013 No! Aspirin and Ticagrelor Is a Much Better Option Presenter: Emmanouil Brilakis October 28, 2013
Presentation TCT 2013 Effect of Ticagrelor on the Outcomes of Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From The PLATelet inhibition and patient Outcomes (PLATO) trial Presenter: Emmanouil Brilakis, Claes Held, Bernhard Meier, Frank Cools, Marc Claeys, Jan Cornel, Philip Aylward, Basil Lewis, Douglas Weaver, Gunnar Brandrup- Wognsen, Susanna Stevens, Lars Wallentin, Stefan James January 31, 2013
Presentation TCT 2013 Double (360mg) Loading Dose Of Ticagrelor In Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Presenter: Dimitrios Alexopoulos, Ioanna Xanthopoulou, Vassilios Gkizas, George Kassimis, Konstantinos Theodoropoulos, Tsigkas Grigorios, Ioannis Chiladakis, Anastasia Damelou, George Hahalis, Periklis Davlouros January 31, 2013
Presentation TCT 2012 Debate: Prasugrel or Ticagrelor Should be Used in Nearly All Cases! Presenter: Dominick Angiolillo October 25, 2012
Presentation TCT 2012 Ticagrelor Update: PLATO: Recent Analyses Presenter: Robert Harrington October 24, 2012
Presentation TCT 2012 Ticagrelor Is the Right Choice: More Potent, Better Data! Presenter: Dimitrios Alexopoulos October 24, 2012
News Conference News TCT 2012 Presentations Examine Multiple Facets of Antiplatelet Agents October 24, 2012
Presentation TCT 2012 Ticagrelor Enhances Adenosine-induced Coronary Vasodilatory Responses in Humans—a Randomised, Double-Blind, Placebo-Controlled, Crossover, Single Centre Study Using... Presenter: Li-Ming Gan, Ann Wittfeldt, H?kan Emanuelsson, Sven Nylander, Magnus Andersson January 03, 2012